ArticlebioRxiv : the preprint server for biology2023
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers.
Husain Yar Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.